20 results
8-K
EX-1.1
PHAT
Phathom Pharmaceuticals Inc
24 May 23
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:14pm
is, and at all times since January 1, 2021 has been, in compliance with all Health Care Laws (defined herein), including, but not limited to, the rules … , “Health Care Laws” shall mean the U.S. Federal Food, Drug and Cosmetic Act (21 U.S.C. § 301 et seq.); the federal Anti-kickback Statute (42 U.S.C. § 1320a
8-K
EX-1.1
3gajg6pw 5qko1ugap0y
17 Dec 20
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
4:26pm
S-3
EX-1.2
e3tb bb7g
10 Nov 20
Shelf registration
5:17pm
10-K
fe1qr
19 Mar 20
Annual report
8:31am
10-Q
3l30y4uysbslymms0z
25 Nov 19
Quarterly report
4:01pm
424B4
9hq83om ue5
28 Oct 19
Prospectus supplement with pricing info
12:00am
S-1/A
EX-1.1
7tuh4cd az2kykiu
15 Oct 19
IPO registration (amended)
6:39am
S-1/A
932fj
15 Oct 19
IPO registration (amended)
6:39am
S-1
EX-10.13
sn2wuao6zead3k6u3yp
30 Sep 19
IPO registration
12:00am
S-1
86na4hh
30 Sep 19
IPO registration
12:00am
DRS/A
ky49rz0lmsgm6cspwbr
30 Aug 19
Draft registration statement (amended)
12:00am
DRS
p2ih s5rjvtn
26 Jul 19
Draft registration statement
12:00am
DRS
EX-10.13
ct40jl8r 7onr1
26 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next